APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Anticoagulant

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Blood Anticoagulant Industry Growth and Trends Forecast to 2032

29 December 2025108 pages

Choose your research edition.

Industry ResearchBlood Anticoagulant Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Anticoagulant Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Blood Anticoagulant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Anticoagulant Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Anticoagulant Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Blood Anticoagulant market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Blood Anticoagulant is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Blood Anticoagulant is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood Anticoagulant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Blood Anticoagulant include Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Keryx Biopharmaceuticals, AstraZeneca, Bayer, Pfizer, Eli Lilly and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Blood Anticoagulant market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Blood Anticoagulant market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Blood Anticoagulant market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Blood Anticoagulant.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Blood Anticoagulant market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Blood Anticoagulant Market by Company

Boehringer Ingelheim

Bristol-Myers Squibb

Daiichi Sankyo

Keryx Biopharmaceuticals

AstraZeneca

Bayer

Pfizer

Eli Lilly

Johnson & Johnson

Sanofi

Blood Anticoagulant Segment by Type

Oral

Injection

Blood Anticoagulant Segment by Application

Hospital

Clinic

Others

Blood Anticoagulant Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Anticoagulant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Anticoagulant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Anticoagulant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Blood Anticoagulant manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Blood Anticoagulant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Injection Table 3. Global Blood Anticoagulant Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Blood Anticoagulant Sales by Type (2021-2026) & (K Units) Table 5. Global Blood Anticoagulant Sales Market Share in Volume by Type (2021-2026) Table 6. Global Blood Anticoagulant Sales by Type (2021-2026) & (US$ Million) Table 7. Global Blood Anticoagulant Sales Market Share in Value by Type (2021-2026) Table 8. Global Blood Anticoagulant Price by Type (2021-2026) & (US$/Unit) Table 9. Global Blood Anticoagulant Sales by Type (2027-2032) & (K Units) Table 10. Global Blood Anticoagulant Sales Market Share in Volume by Type (2027-2032) Table 11. Global Blood Anticoagulant Sales by Type (2027-2032) & (US$ Million) Table 12. Global Blood Anticoagulant Sales Market Share in Value by Type (2027-2032) Table 13. Global Blood Anticoagulant Price by Type (2027-2032) & (US$/Unit) Table 14. North America Blood Anticoagulant Sales by Type (2021-2026) & (K Units) Table 15. North America Blood Anticoagulant Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Blood Anticoagulant Sales by Type (2021-2026) & (K Units) Table 17. Europe Blood Anticoagulant Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Blood Anticoagulant Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Blood Anticoagulant Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Blood Anticoagulant Sales by Type (2021-2026) & (K Units) Table 21. Latin America Blood Anticoagulant Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Blood Anticoagulant Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Blood Anticoagulant Sales by Type (2021-2026) & (US$ Million) Table 24. Blood Anticoagulant Industry Trends Table 25. Blood Anticoagulant Industry Drivers Table 26. Blood Anticoagulant Industry Opportunities and Challenges Table 27. Blood Anticoagulant Industry Restraints Table 28. Global Blood Anticoagulant Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Blood Anticoagulant Revenue Market Share by Company (2021-2026) Table 30. Global Blood Anticoagulant Sales by Company (2021-2026) & (K Units) Table 31. Global Blood Anticoagulant Sales Share by Company (2021-2026) Table 32. Global Blood Anticoagulant Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Blood Anticoagulant Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Blood Anticoagulant Major Company Production Sites and Headquarters Table 35. Global Blood Anticoagulant Company, Product Type & Application Table 36. Global Blood Anticoagulant Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Blood Anticoagulant by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Blood Anticoagulant Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Blood Anticoagulant Sales by Region (2021-2026) & (K Units) Table 41. Global Blood Anticoagulant Sales Market Share in Volume by Region (2021-2026) Table 42. Global Blood Anticoagulant Sales by Region (2021-2026) & (US$ Million) Table 43. Global Blood Anticoagulant Sales Market Share in Value by Region (2021-2026) Table 44. Global Blood Anticoagulant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Blood Anticoagulant Sales by Region (2027-2032) & (K Units) Table 46. Global Blood Anticoagulant Sales Market Share in Volume by Region (2027-2032) Table 47. Global Blood Anticoagulant Sales by Region (2027-2032) & (US$ Million) Table 48. Global Blood Anticoagulant Sales Market Share in Value by Region (2027-2032) Table 49. Global Blood Anticoagulant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Blood Anticoagulant Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Blood Anticoagulant Sales by Application (2021-2026) & (K Units) Table 52. Global Blood Anticoagulant Sales Market Share in Volume by Application (2021-2026) Table 53. Global Blood Anticoagulant Sales by Application (2021-2026) & (US$ Million) Table 54. Global Blood Anticoagulant Sales Market Share in Value by Application (2021-2026) Table 55. Global Blood Anticoagulant Price by Application (2021-2026) & (US$/Unit) Table 56. Global Blood Anticoagulant Sales by Application (2027-2032) & (K Units) Table 57. Global Blood Anticoagulant Sales Market Share in Volume by Application (2027-2032) Table 58. Global Blood Anticoagulant Sales by Application (2027-2032) & (US$ Million) Table 59. Global Blood Anticoagulant Sales Market Share in Value by Application (2027-2032) Table 60. Global Blood Anticoagulant Price by Application (2027-2032) & (US$/Unit) Table 61. North America Blood Anticoagulant Sales by Application (2021-2026) & (K Units) Table 62. North America Blood Anticoagulant Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Blood Anticoagulant Sales by Application (2021-2026) & (K Units) Table 64. Europe Blood Anticoagulant Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Blood Anticoagulant Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Blood Anticoagulant Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Blood Anticoagulant Sales by Application (2021-2026) & (K Units) Table 68. Latin America Blood Anticoagulant Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Blood Anticoagulant Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Blood Anticoagulant Sales by Application (2021-2026) & (US$ Million) Table 71. Boehringer Ingelheim Company Information Table 72. Boehringer Ingelheim Business Overview Table 73. Boehringer Ingelheim Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Boehringer Ingelheim Blood Anticoagulant Product Portfolio Table 75. Boehringer Ingelheim Recent Development Table 76. Bristol-Myers Squibb Company Information Table 77. Bristol-Myers Squibb Business Overview Table 78. Bristol-Myers Squibb Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bristol-Myers Squibb Blood Anticoagulant Product Portfolio Table 80. Bristol-Myers Squibb Recent Development Table 81. Daiichi Sankyo Company Information Table 82. Daiichi Sankyo Business Overview Table 83. Daiichi Sankyo Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Daiichi Sankyo Blood Anticoagulant Product Portfolio Table 85. Daiichi Sankyo Recent Development Table 86. Keryx Biopharmaceuticals Company Information Table 87. Keryx Biopharmaceuticals Business Overview Table 88. Keryx Biopharmaceuticals Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Keryx Biopharmaceuticals Blood Anticoagulant Product Portfolio Table 90. Keryx Biopharmaceuticals Recent Development Table 91. AstraZeneca Company Information Table 92. AstraZeneca Business Overview Table 93. AstraZeneca Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. AstraZeneca Blood Anticoagulant Product Portfolio Table 95. AstraZeneca Recent Development Table 96. Bayer Company Information Table 97. Bayer Business Overview Table 98. Bayer Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Bayer Blood Anticoagulant Product Portfolio Table 100. Bayer Recent Development Table 101. Pfizer Company Information Table 102. Pfizer Business Overview Table 103. Pfizer Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Pfizer Blood Anticoagulant Product Portfolio Table 105. Pfizer Recent Development Table 106. Eli Lilly Company Information Table 107. Eli Lilly Business Overview Table 108. Eli Lilly Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Eli Lilly Blood Anticoagulant Product Portfolio Table 110. Eli Lilly Recent Development Table 111. Johnson & Johnson Company Information Table 112. Johnson & Johnson Business Overview Table 113. Johnson & Johnson Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Johnson & Johnson Blood Anticoagulant Product Portfolio Table 115. Johnson & Johnson Recent Development Table 116. Sanofi Company Information Table 117. Sanofi Business Overview Table 118. Sanofi Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Sanofi Blood Anticoagulant Product Portfolio Table 120. Sanofi Recent Development Table 121. North America Blood Anticoagulant Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Blood Anticoagulant Sales by Country (2021-2026) & (K Units) Table 123. North America Blood Anticoagulant Sales Market Share by Country (2021-2026) Table 124. North America Blood Anticoagulant Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Blood Anticoagulant Sales Market Share Forecast by Country (2027-2032) Table 126. North America Blood Anticoagulant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Blood Anticoagulant Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Blood Anticoagulant Market Share by Country (2021-2026) Table 129. North America Blood Anticoagulant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Blood Anticoagulant Market Share Forecast by Country (2027-2032) Table 131. Europe Blood Anticoagulant Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Blood Anticoagulant Sales by Country (2021-2026) & (K Units) Table 133. Europe Blood Anticoagulant Sales Market Share by Country (2021-2026) Table 134. Europe Blood Anticoagulant Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Blood Anticoagulant Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Blood Anticoagulant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Blood Anticoagulant Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Blood Anticoagulant Market Share by Country (2021-2026) Table 139. Europe Blood Anticoagulant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Blood Anticoagulant Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Blood Anticoagulant Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Blood Anticoagulant Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Blood Anticoagulant Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Blood Anticoagulant Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Blood Anticoagulant Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Blood Anticoagulant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Blood Anticoagulant Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Blood Anticoagulant Market Share by Country (2021-2026) Table 149. Asia-Pacific Blood Anticoagulant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Blood Anticoagulant Market Share Forecast by Country (2027-2032) Table 151. Latin America Blood Anticoagulant Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Blood Anticoagulant Sales by Country (2021-2026) & (K Units) Table 153. Latin America Blood Anticoagulant Sales Market Share by Country (2021-2026) Table 154. Latin America Blood Anticoagulant Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Blood Anticoagulant Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Blood Anticoagulant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Blood Anticoagulant Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Blood Anticoagulant Market Share by Country (2021-2026) Table 159. Latin America Blood Anticoagulant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Blood Anticoagulant Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Blood Anticoagulant Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Blood Anticoagulant Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Blood Anticoagulant Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Blood Anticoagulant Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Blood Anticoagulant Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Blood Anticoagulant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Blood Anticoagulant Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Blood Anticoagulant Market Share by Country (2021-2026) Table 169. Middle East and Africa Blood Anticoagulant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Blood Anticoagulant Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Blood Anticoagulant Distributors List Table 174. Blood Anticoagulant Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Blood Anticoagulant Image Figure 2. Global Blood Anticoagulant Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Anticoagulant Market Size (2021-2032) & (US$ Million) Figure 4. Global Blood Anticoagulant Sales (2021-2032) & (K Units) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Blood Anticoagulant Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Blood Anticoagulant Market Share by Type 2025 VS 2032 Figure 11. North America Blood Anticoagulant Sales Market Share in Volume by Type in 2025 Figure 12. North America Blood Anticoagulant Sales Market Share in Value by Type in 2025 Figure 13. Europe Blood Anticoagulant Sales Market Share in Volume by Type in 2025 Figure 14. Europe Blood Anticoagulant Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Blood Anticoagulant Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Blood Anticoagulant Sales Market Share in Value by Type in 2025 Figure 17. Latin America Blood Anticoagulant Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Blood Anticoagulant Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Blood Anticoagulant Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Blood Anticoagulant Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Blood Anticoagulant Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Blood Anticoagulant Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Blood Anticoagulant Market Share by Application 2025 VS 2032 Figure 31. North America Blood Anticoagulant Sales Market Share in Volume by Application in 2025 Figure 32. North America Blood Anticoagulant Sales Market Share in Value by Application in 2025 Figure 33. Europe Blood Anticoagulant Sales Market Share in Volume by Application in 2025 Figure 34. Europe Blood Anticoagulant Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Blood Anticoagulant Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Blood Anticoagulant Sales Market Share in Value by Application in 2025 Figure 37. Latin America Blood Anticoagulant Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Blood Anticoagulant Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Blood Anticoagulant Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Blood Anticoagulant Sales Market Share in Value by Application in 2025 Figure 41. North America Blood Anticoagulant Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Blood Anticoagulant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Blood Anticoagulant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Blood Anticoagulant Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Blood Anticoagulant Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Blood Anticoagulant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Blood Anticoagulant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Blood Anticoagulant Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Blood Anticoagulant Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Blood Anticoagulant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Blood Anticoagulant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Blood Anticoagulant Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Blood Anticoagulant Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Blood Anticoagulant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Blood Anticoagulant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Blood Anticoagulant Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Blood Anticoagulant Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Blood Anticoagulant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Blood Anticoagulant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Blood Anticoagulant Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Blood Anticoagulant Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Blood Anticoagulant Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Daiichi Sankyo
  • Keryx Biopharmaceuticals
  • AstraZeneca
  • Bayer
  • Pfizer
  • Eli Lilly
  • Johnson & Johnson
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Blood Anticoagulant Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Blood Anticoagulant Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Blood Anticoagulant Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Injection
  8. 1.4 Global Blood Anticoagulant Market Size by Type
  9. 1.4.1 Global Blood Anticoagulant Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Blood Anticoagulant Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Blood Anticoagulant Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Blood Anticoagulant Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Blood Anticoagulant Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Blood Anticoagulant Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Blood Anticoagulant Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Blood Anticoagulant Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Blood Anticoagulant Industry Trends
  2. 2.2 Blood Anticoagulant Industry Drivers
  3. 2.3 Blood Anticoagulant Industry Opportunities and Challenges
  4. 2.4 Blood Anticoagulant Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Blood Anticoagulant Revenue (2021-2026)
  2. 3.2 Global Top Players by Blood Anticoagulant Sales (2021-2026)
  3. 3.3 Global Top Players by Blood Anticoagulant Price (2021-2026)
  4. 3.4 Global Blood Anticoagulant Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Blood Anticoagulant Major Company Production Sites & Headquarters
  6. 3.6 Global Blood Anticoagulant Company, Product Type & Application
  7. 3.7 Global Blood Anticoagulant Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Blood Anticoagulant Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Blood Anticoagulant Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Blood Anticoagulant Tier 1, Tier 2, and Tier 3
4 Blood Anticoagulant Regional Status and Outlook
  1. 4.1 Global Blood Anticoagulant Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Blood Anticoagulant Historic Market Size by Region
  3. 4.2.1 Global Blood Anticoagulant Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Blood Anticoagulant Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Blood Anticoagulant Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Blood Anticoagulant Forecasted Market Size by Region
  7. 4.3.1 Global Blood Anticoagulant Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Blood Anticoagulant Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Blood Anticoagulant Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Blood Anticoagulant by Application
  1. 5.1 Blood Anticoagulant Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Blood Anticoagulant Market Size by Application
  6. 5.2.1 Global Blood Anticoagulant Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Blood Anticoagulant Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Blood Anticoagulant Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Blood Anticoagulant Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Blood Anticoagulant Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Blood Anticoagulant Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Blood Anticoagulant Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Blood Anticoagulant Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Blood Anticoagulant Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Blood Anticoagulant Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 Bristol-Myers Squibb
  8. 6.2.1 Bristol-Myers Squibb Company Information
  9. 6.2.2 Bristol-Myers Squibb Business Overview
  10. 6.2.3 Bristol-Myers Squibb Blood Anticoagulant Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bristol-Myers Squibb Blood Anticoagulant Product Portfolio
  12. 6.2.5 Bristol-Myers Squibb Recent Developments
  13. 6.3 Daiichi Sankyo
  14. 6.3.1 Daiichi Sankyo Company Information
  15. 6.3.2 Daiichi Sankyo Business Overview
  16. 6.3.3 Daiichi Sankyo Blood Anticoagulant Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Daiichi Sankyo Blood Anticoagulant Product Portfolio
  18. 6.3.5 Daiichi Sankyo Recent Developments
  19. 6.4 Keryx Biopharmaceuticals
  20. 6.4.1 Keryx Biopharmaceuticals Company Information
  21. 6.4.2 Keryx Biopharmaceuticals Business Overview
  22. 6.4.3 Keryx Biopharmaceuticals Blood Anticoagulant Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Keryx Biopharmaceuticals Blood Anticoagulant Product Portfolio
  24. 6.4.5 Keryx Biopharmaceuticals Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Blood Anticoagulant Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Blood Anticoagulant Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Blood Anticoagulant Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer Blood Anticoagulant Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Blood Anticoagulant Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Blood Anticoagulant Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Eli Lilly
  44. 6.8.1 Eli Lilly Company Information
  45. 6.8.2 Eli Lilly Business Overview
  46. 6.8.3 Eli Lilly Blood Anticoagulant Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Eli Lilly Blood Anticoagulant Product Portfolio
  48. 6.8.5 Eli Lilly Recent Developments
  49. 6.9 Johnson & Johnson
  50. 6.9.1 Johnson & Johnson Company Information
  51. 6.9.2 Johnson & Johnson Business Overview
  52. 6.9.3 Johnson & Johnson Blood Anticoagulant Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Johnson & Johnson Blood Anticoagulant Product Portfolio
  54. 6.9.5 Johnson & Johnson Recent Developments
  55. 6.10 Sanofi
  56. 6.10.1 Sanofi Company Information
  57. 6.10.2 Sanofi Business Overview
  58. 6.10.3 Sanofi Blood Anticoagulant Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sanofi Blood Anticoagulant Product Portfolio
  60. 6.10.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America Blood Anticoagulant Sales by Country
  2. 7.1.1 North America Blood Anticoagulant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Blood Anticoagulant Sales by Country (2021-2026)
  4. 7.1.3 North America Blood Anticoagulant Sales Forecast by Country (2027-2032)
  5. 7.2 North America Blood Anticoagulant Market Size by Country
  6. 7.2.1 North America Blood Anticoagulant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Blood Anticoagulant Market Size by Country (2021-2026)
  8. 7.2.3 North America Blood Anticoagulant Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Blood Anticoagulant Sales by Country
  2. 8.1.1 Europe Blood Anticoagulant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Blood Anticoagulant Sales by Country (2021-2026)
  4. 8.1.3 Europe Blood Anticoagulant Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Blood Anticoagulant Market Size by Country
  6. 8.2.1 Europe Blood Anticoagulant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Blood Anticoagulant Market Size by Country (2021-2026)
  8. 8.2.3 Europe Blood Anticoagulant Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Blood Anticoagulant Sales by Country
  2. 9.1.1 Asia-Pacific Blood Anticoagulant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Blood Anticoagulant Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Blood Anticoagulant Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Blood Anticoagulant Market Size by Country
  6. 9.2.1 Asia-Pacific Blood Anticoagulant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Blood Anticoagulant Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Blood Anticoagulant Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Blood Anticoagulant Sales by Country
  2. 10.1.1 South America Blood Anticoagulant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Blood Anticoagulant Sales by Country (2021-2026)
  4. 10.1.3 South America Blood Anticoagulant Sales Forecast by Country (2027-2032)
  5. 10.2 South America Blood Anticoagulant Market Size by Country
  6. 10.2.1 South America Blood Anticoagulant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Blood Anticoagulant Market Size by Country (2021-2026)
  8. 10.2.3 South America Blood Anticoagulant Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Blood Anticoagulant Sales by Country
  2. 11.1.1 Middle East and Africa Blood Anticoagulant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Blood Anticoagulant Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Blood Anticoagulant Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Blood Anticoagulant Market Size by Country
  6. 11.2.1 Middle East and Africa Blood Anticoagulant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Blood Anticoagulant Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Blood Anticoagulant Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Blood Anticoagulant Value Chain Analysis
  2. 12.1.1 Blood Anticoagulant Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Blood Anticoagulant Production Mode & Process
  7. 12.2 Blood Anticoagulant Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Blood Anticoagulant Distributors
  10. 12.2.3 Blood Anticoagulant Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst